Cargando…

Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei

Systemic mycoses are one major cause of morbidity/mortality among immunocompromised/debilitated individuals. Studying the mechanism of action is a strategy to develop safer/potent antifungals, warning resistance emergence. The major goal of this study was to elucidate the mechanism of action of thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerqueira, Fátima, Maia, Marta, Gabriel, Carla, Medeiros, Rui, Cravo, Sara, Ribeiro, Ana Isabel, Dantas, Daniela, Dias, Alice Maria, Saraiva, Lucília, Raimundo, Liliana, Pinto, Eugénia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917925/ https://www.ncbi.nlm.nih.gov/pubmed/33673152 http://dx.doi.org/10.3390/antibiotics10020183

Ejemplares similares

Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol
por: Sachivkina, Nadezhda, et al.
Publicado: (2021)

Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates
por: Güzel, Ahmet Bariş, et al.
Publicado: (2013)

Promising antifungal activity of new oxadiazole against Candida krusei
por: Faria, Daniella Renata, et al.
Publicado: (2020)

Cardiac Candida krusei infection
por: Wiwanitkit, Viroj
Publicado: (2010)

Molecular Phylogenetic Analysis of Candida krusei
por: Domán, Marianna, et al.
Publicado: (2022)

Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of Candida krusei
por: Wu, Yongqin, et al.
Publicado: (2020)

Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida
por: Hospenthal, Duane R, et al.
Publicado: (2006)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells
por: Navarro-Arias, María J, et al.
Publicado: (2019)

Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei
por: Das, Bhaskar, et al.
Publicado: (2016)

Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
por: Scorzoni, Liliana, et al.
Publicado: (2013)

Upregulation of the ERG11 gene in Candida krusei by azoles
por: Tavakoli, M., et al.
Publicado: (2010)

Renal allograft pyelonephritis and fungemia due to Candida krusei
por: Westervelt, Justin D., et al.
Publicado: (2014)

Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei
por: Gong, Jie, et al.
Publicado: (2018)

Case report: Candida krusei spondylitis in an immunocompromised patient
por: Overgaauw, Audrey J. C., et al.
Publicado: (2020)

A Trypsin Inhibitor from Tecoma stans Leaves Inhibits Growth and Promotes ATP Depletion and Lipid Peroxidation in Candida albicans and Candida krusei
por: Patriota, Leydianne L. S., et al.
Publicado: (2016)

Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience
por: Choi, Hee Kyoung, et al.
Publicado: (2009)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

A cluster of Candida krusei infections in a haematological unit
por: Hautala, Timo, et al.
Publicado: (2007)

Risk Factors and Mortality Associated with Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2017)

Biosorption Performance of Encapsulated Candida krusei for the removal of Copper(II)
por: Luk, Chi Him Jim, et al.
Publicado: (2017)

P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares
por: Sharifzadeh, Aghil, et al.
Publicado: (2022)

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
por: Ishida, Kelly, et al.
Publicado: (2011)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Candida krusei form mycelia along agar surfaces towards each other and other Candida species
por: Fleischmann, Jacob, et al.
Publicado: (2017)

Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species
por: Mohammadi, Faezeh, et al.
Publicado: (2021)

The Bovhyaluronidase Azoximer (Longidaza(®)) Disrupts Candida albicans and Candida albicans-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals
por: Gatina, Alina, et al.
Publicado: (2022)

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
por: Rhimi, Wafa, et al.
Publicado: (2020)

In Vitro Antifungal Activity of Equol against Candida albicans
por: Lee, Jeong Ah, et al.
Publicado: (2010)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
por: Ou, Huang-Tz, et al.
Publicado: (2017)

Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019)

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
por: Spettel, Kathrin, et al.
Publicado: (2019)

Antifungal Resistance Profile, Biofilm Formation, and Virulence Factor Production in Candida krusei Isolates From HIV-Infected Patients in Cameroon
por: Kountchou, Cyrille Levis, et al.
Publicado: (2023)

Prolonged Outbreak of Candida krusei Candidemia in Paediatric Ward of Tertiary Care Hospital
por: Kaur, Harsimran, et al.
Publicado: (2020)

Hsp21 Potentiates Antifungal Drug Tolerance in Candida albicans
por: Mayer, François L., et al.
Publicado: (2013)

Effects of Chitosan on Candida albicans: Conditions for Its Antifungal Activity
por: Peña, Antonio, et al.
Publicado: (2013)

High Virulence and Antifungal Resistance in Clinical Strains of Candida albicans
por: Monroy-Pérez, Eric, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8cra4iq5mbbddvvtjjn9bf9gp1